The single treatment, which uses the body's own enriched blood platelets called Platelet Rich Fibrin Matrix or PRFM, is based on the same technology used successfully to restore tissue in the face, knee and other parts of the body. In a procedure that takes less than 30 minutes, blood platelets are drawn from the patient and spun in a centrifuge to release powerful growth factors. Then, using a tiny needle and a local anesthetic cream that makes it virtually painless, the platelet-enriched serum is injected into only two parts of the vagina.
"The process can stimulate the growth of more responsive, younger-looking vaginal tissue that can restore sexual vitality and function," says Dr. G. Pat Sharratt, D.O. of the Anti-Aging Institute. "The results reported by many women, and they've been dramatic, include greater sexual desire and arousal, and an increased ability to achieve orgasm, even in those who have had difficulty in the past."
Sharratt notes that the O-Shot® is a natural procedure that requires no drugs or surgery and causes no allergic reactions. Side effects are rare and minimal. The treatment can also be effective in improving or eliminating some types of urinary incontinence caused by a decline in function of vaginal tissue. Results can vary per individual.
Sharratt was trained, licensed and certified for the procedure by Dr. Charles Runels, M.D., the inventor of the O-Shot® and creator of the widely popular Priapus Shot® for male sexual dysfunction. The O-Shot® can produce results almost immediately, reaches its full effect in a few weeks and has been reported by women to last from nine months to as long as three years.
"Finally, with all the emphasis being placed in recent years on male erectile dysfunction, there's a solution for the millions of women who likewise suffer from a loss of sexual fulfillment," says Dr. Robert Newberry, M.D., Medical Director of the Institute, "And we're very pleased to now offer the O-Shot® at the Dallas Anti-Aging Institute."
For ad rates, call Mike McCurdy at 877-634-9180 or email at [email protected] We have over 7,000 journalists who are subscribers.